Articles
- Article
- 5 min read
7508Background: No FDA approved treatments exist for relapsed/refractory (RR) AL Amyloidosis....
- Article
- 5 min read
AbstractBackground: No FDA approved treatments exist for relapsed/refractory (RR) AL Amyloidosis....
- Article
- 4 min read
No FDA approved drugs exist for relapsed/refractory (RR) AL Amyloidosis. CAR-T...
- Article
- 10 min read
The FDA granted Regenerative Medicine Advanced Therapy designation to NXC-201 for...
- Article
- 3 min read
Vaishali Sanchorawala, MD, Boston University School of Medicine, Boston, MA, discusses...
- Article
- 5 min read
Shahzad Raza, MD, shares preliminary data from the NEXICART-2 trial of...
- Article
- 4 min read
Myeloma-like approach shows early promise for rare plasma cell disorder...
- Article
- 5 min read
Heather Landau, MD, Memorial Sloan Kettering Cancer Center, New York, NY,...